Efficacy and safety of dabigatran, rivaroxaban, and warfarin for stroke prevention in Chinese patients with atrial fibrillation: the Hong Kong Atrial Fibrillation Project

BACKGROUND: Little is known about the comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation (AF) patients. Our aim was to compare the ischemic stroke risk reduction and incidence of intracranial hemorrhage (ICH...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cardiol
Auteurs principaux: Li, Wen‐Hua, Huang, Duo, Chiang, Chern‐En, Lau, Chu‐Pak, Tse, Hung‐Fat, Chan, Esther W., Wong, Ian C.K., Lip, Gregory Y. H., Chan, Pak‐Hei, Siu, Chung‐Wah
Format: Artigo
Langue:Inglês
Publié: Wiley Periodicals, Inc. 2016
Sujets:
Clinical Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490525/
https://ncbi.nlm.nih.gov/pubmed/27893153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22649
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires